首站-论文投稿智能助手
典型文献
Advances in lung cancer screening and early detection
文献摘要:
Lung cancer is associated with a heavy cancer-related burden in terms of patients' physical and mental health worldwide. Two randomized controlled trials, the US-National Lung Screening Trial (NLST) and Nederlands-Leuvens Longkanker Screenings Onderzoek (NELSON), indicated that low-dose CT (LDCT) screening results in a statistically significant decrease in mortality in patients with lung cancer, LDCT has become the standard approach for lung cancer screening. However, many issues in lung cancer screening remain unresolved, such as the screening criteria, high false-positive rate, and radiation exposure. This review first summarizes recent studies on lung cancer screening from the US, Europe, and Asia, and discusses risk-based selection for screening and the related issues. Second, an overview of novel techniques for the differential diagnosis of pulmonary nodules, including artificial intelligence and molecular biomarker-based screening, is presented. Third, current explorations of strategies for suspected malignancy are summarized. Overall, this review aims to help clinicians understand recent progress in lung cancer screening and alleviate the burden of lung cancer.
文献关键词:
作者姓名:
Caichen Li;Huiting Wang;Yu Jiang;Wenhai Fu;Xiwen Liu;Ran Zhong;Bo Cheng;Feng Zhu;Yang Xiang;Jianxing He;Wenhua Liang
作者机构:
Department of Thoracic Oncology and Surgery,the First Affiliated Hospital of Guangzhou Medical University,China National Center for Respiratory Medicine,China State Key Laboratory of Respiratory Disease&National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,Guangzhou 510120,China;Dongguan Affiliated Hospital of Southern Medical University,Dongguan People Hospital,Dongguan 523059,China;Department of Internal Medicine,Detroit Medical Center Sinai-Grace Hospital,Detroit,Michigan 48235,USA;Department of Thoracic Surgery,Nanfang Hospital of Southern Medical University,Guangzhou 510515,China;Department of Oncology,the First People's Hospital of Zhaoqing,Zhaoqing 526020,China
引用格式:
[1]Caichen Li;Huiting Wang;Yu Jiang;Wenhai Fu;Xiwen Liu;Ran Zhong;Bo Cheng;Feng Zhu;Yang Xiang;Jianxing He;Wenhua Liang-.Advances in lung cancer screening and early detection)[J].癌症生物学与医学(英文版),2022(05):591-608
A类:
NLST,Nederlands,Leuvens,Longkanker,Screenings,Onderzoek,NELSON
B类:
Advances,lung,cancer,screening,early,detection,Lung,associated,heavy,related,burden,terms,patients,physical,mental,health,worldwide,Two,randomized,controlled,trials,US,National,Trial,indicated,that,low,dose,LDCT,results,statistically,significant,decrease,mortality,has,become,standard,approach,However,many,issues,remain,unresolved,such,criteria,high,false,positive,radiation,exposure,This,review,first,summarizes,recent,studies,from,Europe,Asia,discusses,risk,selection,Second,overview,novel,techniques,differential,diagnosis,pulmonary,nodules,including,artificial,intelligence,molecular,biomarker,presented,Third,current,explorations,strategies,suspected,malignancy,are,summarized,Overall,this,aims,help,clinicians,understand,progress,alleviate
AB值:
0.572848
相似文献
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Wu Zheng;Tan Fengwei;Yang Zhuoyu;Wang Fei;Cao Wei;Qin Chao;Dong Xuesi;Zheng Yadi;Luo Zilin;Zhao Liang;Yu Yiwen;Xu Yongjie;Ren Jiansong;Shi Jufang;Chen Hongda;Li Jiang;Tang Wei;Shen Sipeng;Wu Ning;Chen Wanqing;Li Ni;He Jie-Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Key Laboratory of Cancer Data Science, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;PET-CT Center, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small-cell lung cancer:A real-world,multicenter,retrospective,controlled study in China
Hanxiao Chen;Xiangjuan Ma;Jie Liu;Yu Yang;Yong Fang;Liping Wang;Jian Fang;Jun Zhao;Minglei Zhuo-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅰ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅱ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Pneumology,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China;Department of Oncology,the 2nd Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Department of Oncology,Sir Run Run Shaw Hospital Zhejiang University School of Medicine,Hangzhou 310020,China;Department of Oncology,Baotou Cancer Hospital,Baotou 014030,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。